Literature DB >> 3262851

The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus.

G L Trick1, R M Burde, M O Gordon, J V Santiago, C Kilo.   

Abstract

In an attempt to elucidate more fully the pathophysiologic basis of early visual dysfunction in patients with diabetes mellitus, color vision (hue discrimination) and spatial resolution (contrast sensitivity) were tested in diabetic patients with little or no retinopathy (n = 57) and age-matched visual normals (n = 35). Some evidence of visual dysfunction was observed in 37.8% of the diabetics with no retinopathy and 60.0% of the diabetics with background retinopathy. Although significant hue discrimination and contrast sensitivity deficits were observed in both groups of diabetic patients, contrast sensitivity was abnormal more frequently than hue discrimination. However, only 5.4% of the diabetics with no retinopathy and 10.0% of the diabetics with background retinopathy exhibited both abnormal hue discrimination and abnormal contrast sensitivity. Contrary to previous reports, blue-yellow (B-Y) and red-green (R-G) hue discrimination deficits were observed with approximately equal frequency. In the diabetic group, contrast sensitivity was reduced at all spatial frequencies tested, but for individual diabetic patients, significant deficits were only evident for the mid-range spatial frequencies. Among diabetic patients, the hue discrimination deficits, but not the contrast sensitivity abnormalities, were correlated with the patients' hemoglobin A1 level. A negative correlation between contrast sensitivity at 6.0 cpd and the duration of diabetes also was observed.

Entities:  

Mesh:

Year:  1988        PMID: 3262851     DOI: 10.1016/s0161-6420(88)33125-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  30 in total

Review 1.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Authors:  Sidra Zafar; Mira Sachdeva; Benjamin J Frankfort; Roomasa Channa
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

2.  The Hermann-Hering grid illusion demonstrates disruption of lateral inhibition processing in diabetes mellitus.

Authors:  Nigel P Davies; Antony B Morland
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

3.  TuebingenCSTest - a useful method to assess the contrast sensitivity function.

Authors:  Tim Schilling; Arne Ohlendorf; Alexander Leube; Siegfried Wahl
Journal:  Biomed Opt Express       Date:  2017-02-10       Impact factor: 3.732

4.  Contrast sensitivity in diabetic pregnancy.

Authors:  T Hellstedt; R Kaaja; K Teramo; I Immonen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-02       Impact factor: 3.117

5.  Risk factors associated with contrast sensitivity loss in diabetic patients.

Authors:  A A Dosso; E R Bonvin; Y Morel; A Golay; J P Assal; P M Leuenberger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

Review 6.  Psychophysical Exams as Early Indicators of Diabetic Retinopathy.

Authors:  Nicola Pescosolido; Giuseppe Buomprisco
Journal:  Eur Endocrinol       Date:  2014-02-28

7.  Spatial visual filtering in diabetes mellitus.

Authors:  Nigel Philip Davies; Antony Bryan Morland
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-07       Impact factor: 3.117

8.  Extent of foveal tritanopia in diabetes mellitus.

Authors:  N Davies; A Morland
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

Review 9.  Interrelationships between the Retinal Neuroglia and Vasculature in Diabetes.

Authors:  Timothy S Kern
Journal:  Diabetes Metab J       Date:  2014-06       Impact factor: 5.376

10.  Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase.

Authors:  Chieh Allen Lee; Guangyuan Li; Mansi D Patel; J Mark Petrash; Beth Ann Benetz; Alex Veenstra; Jaume Amengual; Johannes von Lintig; Christopher J Burant; Johnny Tang; Timothy S Kern
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-02       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.